Vertex Pharmaceuticals, founded in 1989, is a Fortune 500 global biotechnology company based in Boston, Massachusetts. It discovers, develops, and commercializes breakthrough treatments for serious diseases, operating across biotechnology, pharmaceuticals, and healthcare verticals.
The company's research encompasses technical domains including cystic fibrosis, cancer therapeutics, inflammatory bowel disease, autoimmune disorders, and neurological conditions. Its culture promotes scientific excellence, collaboration, creativity, rigorous inquiry, and bold thinking.
